Drug Shortage Report for PMS-ZOLMITRIPTAN
| Report ID | 55747 |
| Drug Identification Number | 02324229 |
| Brand name | PMS-ZOLMITRIPTAN |
| Common or Proper name | ZOLMITRIPTAN |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | ZOLMITRIPTAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-30 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-09 |
| Shortage status | Resolved |
| Updated date | 2020-06-10 |
| Company comments | Product to be discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2018-07-13 | French | Compare |
| v1 | 2018-07-13 | English | Compare |